Network-1 Technologies, Inc. (NTIP)
NYSEAMERICAN: NTIP · Real-Time Price · USD
1.624
+0.054 (3.42%)
At close: Aug 30, 2024, 4:00 PM
1.630
+0.006 (0.38%)
After-hours: Aug 30, 2024, 6:17 PM EDT
Network-1 Technologies Revenue
Network-1 Technologies had revenue of $100.00K in the quarter ending June 30, 2024, a decrease of -64.66%. This brings the company's revenue in the last twelve months to $1.88M, up 129.39% year-over-year. In the year 2023, Network-1 Technologies had annual revenue of $2.60M.
Revenue (ttm)
$1.88M
Revenue Growth
+129.39%
P/S Ratio
20.36
Revenue / Employee
$940,500
Employees
2
Market Cap
37.58M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CPI Aerostructures | 83.79M |
RF Industries | 61.09M |
Dragonfly Energy Holdings | 52.04M |
CDT Environmental Technology Investment Holdings | 34.21M |
Senstar Technologies | 33.72M |
TechPrecision | 30.50M |
Knightscope | 11.79M |
A2Z Smart Technologies | 7.14M |
NTIP News
- 4 days ago - Network-1 Declares Semi-Annual Dividend - Accesswire
- 19 days ago - Network-1 Reports Second Quarter Results - Accesswire
- 4 months ago - Network-1 Reports First Quarter 2024 Results - Accesswire
- 6 months ago - Network-1 Reports 2023 Year-End Financial Results - Accesswire
- 6 months ago - Network-1 Receives New Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 51 Patents Worldwide - Accesswire
- 10 months ago - Network-1 Reports Third Quarter Results - Accesswire
- 1 year ago - ILiAD Biotechnologies Reports First-ever Demonstration of Protection Against B. pertussis Colonization in Phase 2b Human Challenge Study of BPZE1 Vaccine - Accesswire
- 1 year ago - Network-1 Receives New eSIM Patent from U.S. Patent Office Expanding Its M2M/IoT Patent Portfolio to 50 Patents Worldwide - Accesswire